Economic modelling assessment of the HPV quadrivalent vaccine in Brazil: A dynamic individual-based approach

► HPV quadrivalent vaccine is very cost-effective for most scenarios analyzed. ► It can also be cost saving depending on the coverage and cost of the vaccine. ► If a booster is needed, the vaccine is considered only cost-effective.